Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Journal of Environmental News.
Press releases published on August 29, 2025
DeFi Development Corp. Announces Launch of DFDV UK, First Solana Treasury Vehicle in the United Kingdom
GlobeNewswire
·
August 29, 2025
BOCA RATON, FL, Aug. 29, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the launch of …
Dynacor Group Declares September 2025 Dividend
GlobeNewswire
·
August 29, 2025
MONTREAL, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Dynacor Group Inc. (TSX: DNG) ("Dynacor" or the "Corporation") announced its monthly dividend payment for September 2025 in the amount of C$0.01333 per common share which will be payable on September 18, 2025, to …
Groupe Dynacor déclare son dividende pour septembre 2025
GlobeNewswire
·
August 29, 2025
MONTRÉAL, 29 août 2025 (GLOBE NEWSWIRE) -- Groupe Dynacor Inc. (TSX : DNG) (« Dynacor » ou la « Société ») a le plaisir d’annoncer la déclaration de son dividende mensuel pour le mois de septembre 2025 au montant de 0,01333$CA par action qui sera payé le …
Prospera Energy Announces Operations Update, Closing of White Tundra Petroleum Acquisition, and Signing of Joint Venture Partnership
GlobeNewswire
·
August 29, 2025
CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera”, “PEI” or the “Corporation”) Operations Update Prospera has maintained strong operational momentum, averaging gross production of 775 boe/d (97% …
Bicycle Toxin Conjugates Clinical Trials FDA Approval Proprietary Technology Cancer Drugs Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bicycle Toxin Conjugates Clinical Trials, Proprietary Platforms …
RNA Polymerase I POL 1 Clinical Trials Companies FDA Approval Development Trends Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global RNA Polymerase I Clinical Trials, Development Trends By Indications, Target Approaches …
Tetraspecific Antibodies Clinical Trials FDA Approval Development Technologies Platforms Market Opportunity Companies Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Tetraspecific Antibodies Clinical Trials, Proprietary Technologies, Therapeutic Approaches …
Bispecific Antibody Drug Conjugates ADC Clinical Trials FDA Approval Companies Commercial Launch Report 2025
GlobeNewswire
·
August 29, 2025
Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape and Market Opportunity Insight 2025 Report Findings and Highlights: First Bispecific Antibody Drug Conjugate …
Galantas Report Financial Results for the Quarter Ended June 30, 2025
GlobeNewswire
·
August 29, 2025
TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (the ‘Company’) is pleased to announce its unaudited financial results for the Quarter ended June 30, 2025. Financial Highlights Highlights of the second quarter 2025 results, which are …
Solar Alliance Announces Resumption of TSXV Trading, Corporate Update
GlobeNewswire
·
August 29, 2025
TORONTO and KNOXVILLE, Tenn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTC: SAENF), a leading solar energy solutions provider focused on the commercial and utility solar sectors, …